{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Amla", "Cardiovascular Disease", "Emblica officinalis", "Pharmacology", "Phyllanthus emblica"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "30386531", "DateRevised": {"Year": "2020", "Month": "10", "Day": "01"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "09", "Day": "25"}], "Language": ["eng"], "ELocationID": ["10.15171/jcvtr.2018.20"], "Journal": {"ISSN": "2008-5117", "JournalIssue": {"Volume": "10", "Issue": "3", "PubDate": {"Year": "2018"}}, "Title": "Journal of cardiovascular and thoracic research", "ISOAbbreviation": "J Cardiovasc Thorac Res"}, "ArticleTitle": "A systematic review on the cardiovascular pharmacology of <i>Emblica officinalis</i> Gaertn.", "Pagination": {"StartPage": "118", "EndPage": "128", "MedlinePgn": "118-128"}, "Abstract": {"AbstractText": ["<b><i>Introduction:</i></b> The <i>Emblica officinalis</i> (EO) fruit has traditionally been considered as a cardioactive medication and has demonstrated remarkable cardiovascular effects in the pharmacological literature. The present study systematically reviews EO's potential for prevention and therapy of cardiovascular diseases (CVD). <b><i>Methods:</i></b> PubMed, ScienceDirect, Scopus, Proquest, Ebsco, Google, Google Scholar, Ovid, and Cochrane databases were searched from 1966 to 2017 for the English and non-English literature using the terms including the cognates of EO including <i>amla, Emblic myrobalan, Emblica officinalis, Emblica pectinata</i> , Indian gooseberry, and <i>Phyllanthus emblica</i> together with antioxidant, arrhythmia, cardioprotective, cardiotoxicity, heart disease, heart failure, hyperlipidemia, hypertension, myocardial dysfunction, and oxidative stress. The inclusion criteria were in vitro, animal, and clinical cardiovascular pharmacological studies conducted on EO and full-text accessibility. The exclusion criterion was studies in which a combination of EO and at least one other plant was investigated. The reference lists of the retrieved articles were also searched manually for additional eligible articles. The methodological quality of clinical trials was assessed by the Jadad scale, and animal studies were evaluated by the ARRIVE checklist. <b><i>Results:</i></b> Nineteen articles concerning the cardiovascular pharmacological effects of EO were included in this review. The plant has shown antiatherogenic, anticoagulant, hypolipidemic, antihypertensive, antioxidant, antiplatelet, and vasodilatory effects as well as lipid deposition inhibitory properties. Moreover, it prevents from doxorubicin and isoproterenol cardiotoxicity and myocardial ischemia/reperfusion injury, and improves vascular endothelial function in animal studies. Some high-quality clinical studies report the vasodilatory and myocardial antioxidant properties as well as anti-platelet aggregation effects of this plant. <b><i>Conclusion:</i></b> EO influences various cardiovascular risk-factors. However, there is not sufficient evidence to confirm the plant efficacy in preventing and treating CVD."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Institute for Islamic and Complementary Medicine, Iran University of Medical Sciences, Tehran, Iran."}, {"Identifier": [], "Affiliation": "School of Persian Medicine, Iran University of Medical Sciences, Tehran, Iran."}], "LastName": "Hashem-Dabaghian", "ForeName": "Fataneh", "Initials": "F"}, {"Identifier": ["0000-0002-9725-3033"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cardiovascular Research Center, Tabriz University of Medical Sciences, Tabriz, Iran."}], "LastName": "Ziaee", "ForeName": "Mojtaba", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cardiovascular Research Center, Tabriz University of Medical Sciences, Tabriz, Iran."}], "LastName": "Ghaffari", "ForeName": "Samad", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Institute of Medicinal Plants, ACECR, Karaj, Iran."}], "LastName": "Nabati", "ForeName": "Farzaneh", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Institute of Medicinal Plants, ACECR, Karaj, Iran."}], "LastName": "Kianbakht", "ForeName": "Saeed", "Initials": "S"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Iran", "MedlineTA": "J Cardiovasc Thorac Res", "NlmUniqueID": "101528712", "ISSNLinking": "2008-5117"}}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1459\u20131544. doi: 10.1016/S0140-6736(16)310121.", "ArticleIdList": ["10.1016/S0140-6736(16)310121", "PMC5388903", "27733281"]}, {"Citation": "Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M. et al. Heart disease and stroke statistics-2016 update: a report from the American Heart Association. Circulation. 2016;133(4):e38\u2013360. doi: 10.1161/CIR.0000000000000350.", "ArticleIdList": ["10.1161/CIR.0000000000000350", "26673558"]}, {"Citation": "Kianbakht S, Hashem Dabaghian F. Antiobesity and anorectic effects of saffron and its constituent crocin in obese Wistar rat. J Med Plant. 2015;14:25\u201333."}, {"Citation": "Kianbakht S, Abasi B, Hashem Dabaghian F. Improved lipid profile in hyperlipidemic patients taking Vaccinium arctostaphylos fruit hydroalcoholic extract: a randomized double-blind placebo-controlled clinical trial. Phytother Res. 2014;28(3):432\u2013436. doi: 10.1002/ptr.5011.", "ArticleIdList": ["10.1002/ptr.5011", "23686894"]}, {"Citation": "Kianbakht S, Nabatai F, Abasi B. Salvia officinalis leaf (sage) extract as add-on to statin therapy in hypercholesterolemic type 2 diabetic patients: a randomized clinical trial. Int J Mol Cell Med. 2016;5(3):141\u2013148.", "ArticleIdList": ["PMC5125366", "27942500"]}, {"Citation": "Sosnowska B, Penson P, Banach M. The role of nutraceuticals in the prevention of cardiovascular disease. Cardiovasc Diagn Ther. 2017;7(Suppl1):S21\u2013S31. doi: 10.21037/cdt.2017.03.20.", "ArticleIdList": ["10.21037/cdt.2017.03.20", "PMC5418215", "28529919"]}, {"Citation": "Khan KH. Roles of Emblica officinalis in medicine - a review. Bot Res Int. 2009;2(4):218\u2013228."}, {"Citation": "Jain SK, Khurdiya DS. Vitami. Vitamin C enrichment of fruit juice based ready-to-serve beverages through blending of Indian gooseberry (Emblica officinalis Gaertn) juice. Plant Foods Hum Nutr. 2004;59(2):63\u201366.", "ArticleIdList": ["15678753"]}, {"Citation": "El-Desouky SK, Ryu SY, Kim YK. A new cytotoxic acylated apigenin glucoside from Phyllanthus emblica L. Nat Prod Res. 2008;22(1):91\u201395.", "ArticleIdList": ["17999342"]}, {"Citation": "Barthakhur NN, Arnold NP. Chemical analysis of the emblic (Phyllanthus emblica L) and its potential as a food source. Sci Hort. 1992;47(1-2):99\u2013105."}, {"Citation": "Rastogi S, Pandey MM, Rawat AK. Traditional herbs: a remedy for cardiovascular disorders. Phytomed. 2016;23(11):1082\u20131089. doi: 10.1016/j.phymed.2015.10.012.", "ArticleIdList": ["10.1016/j.phymed.2015.10.012", "26656228"]}, {"Citation": "Aghili M. Makhzan al adviye. Tehran: Sabz Avang; 2004."}, {"Citation": "Sobhani Z, Nami SR, Emami SA, Sahebkar A, Javadi B. Medicinal plants targeting cardiovascular diseases in view of Avicenna. Curr Pharm Des. 2017;23(17):2428\u20132443. doi: 10.2174/1381612823666170215104101.", "ArticleIdList": ["10.2174/1381612823666170215104101", "28215156"]}, {"Citation": "Ibn Sina M. Al-Qanun fi al-tib. Beirut: Al Alami Lematbutat; 2005."}, {"Citation": "Ghorbani F, Nazem E, Imani A, Faghihi M, Keshavarz M. Cardiotonic drugs from the Avicenna\u2019s point of view. Iran J Public Health. 2015;44(1):153\u2013154.", "ArticleIdList": ["PMC4450009", "26060793"]}, {"Citation": "Mirunalini S, Vaithiyanathan V, Krishnaveni M. Amla: a novel Ayurvedic herb as a functional food for health benefits \u2013 a mini review. Int J Pharm Pharm Sci. 2013;5(Suppl1):1\u20134."}, {"Citation": "Dasaroju S, Gottumukkala KM. Current trends in the research of Emblica officinalis (amla): a pharmaceutical perspective. Int J Pharm Sci Rev Res. 2014;24(2):150\u2013159."}, {"Citation": "Jain R, Pandey R, Mahant RN, Rathore DS. A review on medicinal importance of Emblica officinalis. Int J Paharm Sci Res. 2015;6(1):72\u201384. doi: 10.13040/IJPSR.0975-8232.", "ArticleIdList": ["10.13040/IJPSR.0975-8232"]}, {"Citation": "Berger VW, Alperson SY. A General Framework for the Evaluation of Clinical Trial Quality. Rev recent clin trials. 2009;4(2):79\u201388.", "ArticleIdList": ["PMC2694951", "19463104"]}, {"Citation": "Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research. Pharmacol Pharmacother. 2010 Jul-Dec;1(2):94\u201399. doi: 10.4103/0976-500X.72351.", "ArticleIdList": ["10.4103/0976-500X.72351", "PMC3043335", "21350617"]}, {"Citation": "Thakur CP, Thakur B, Singh S, Sinha PK, Sinha SK. The Ayurvedic medicines Haritaki, Amla and Bahira reduce cholesterol-induced atherosclerosis in rabbits. Int J Cardiol. 1988;21(2):167\u2013175.", "ArticleIdList": ["3225068"]}, {"Citation": "Mathur R, Sharma A, Dixit VP, Varma M.. Hypolipidemic effect of fruit juice of Emblica officinalis in cholesterol-fed rabbits. J Ethnopharmacol. 1996;50(2):61\u201368.", "ArticleIdList": ["8866725"]}, {"Citation": "Anila L, Vijayalakshmi NR. Flavonoids from Emblica officinalis and Mangifera indica\u2013effectiveness for dyslipidemia. J Ethnopharmacol. 2002;79(1):81\u201387.", "ArticleIdList": ["11744299"]}, {"Citation": "Bhattacharya SK, Bhattacharya A, Sairam K, Ghosal S. Effect of bioactive tannoid principles of Emblica officinalis on ischemia-reperfusion-induced oxidative stress in rat heart. Phytomed. 2002;9(2):171\u2013174.", "ArticleIdList": ["11995952"]}, {"Citation": "Rajak S, Banerjee SK, Sood S, Dinda AK, Gupta YK, Gupta SK. et al. Emblica officinalis causes myocardial adaptation and protects against oxidative stress in ischemic-reperfusion injury in rats. Phytother Res. 2004;18(1):54\u201360. doi: 10.1002/ptr.1367.", "ArticleIdList": ["10.1002/ptr.1367", "14750202"]}, {"Citation": "Antony B, Merina B, Sheeba V, Mukkadan J. Effect of standardized amla extract on atherosclerosis and dyslipidemia. Ind J Pharm Sci. 2006;68(4):437\u2013441."}, {"Citation": "Patel SS, Goyal RK. Prevention of diabetes-induced myocardial dysfunction in rats using the juice of the Emblica officinalis fruit. Exp Clin Cardiol. 2011;16(3):87\u201391.", "ArticleIdList": ["PMC3209545", "22065939"]}, {"Citation": "Bhatia J, Tabassum F, Sharma AK, Bharti S, Golechha M, Joshi S. et al. Emblica officinalis exerts antihypertensive effect in a rat model of DOCA-salt-induced hypertension: role of (p) eNOS, NO and oxidative stress. Cardiovasc Toxicol. 2011;11(3):272\u2013279. doi: 10.1007/s12012-011-9122-2.", "ArticleIdList": ["10.1007/s12012-011-9122-2", "21748534"]}, {"Citation": "Ojha S, Golechha M, Kumari S, Arya DS. Protective effect of Emblica officinalis (amla) on isoproterenol-induced cardiotoxicity in rats. Toxicol Ind Health. 2012;28(5):399\u2013411. doi: 10.1177/0748233711413798.", "ArticleIdList": ["10.1177/0748233711413798", "22033422"]}, {"Citation": "Santoshkumar J, Manjunath S. Sakhare Pranavkumar M A study of anti-hyperlipidemia, hypolipidemic and anti-atherogenic activity of fruit of Emblica officinalis (amla) in high fat fed albino rats. Int J Med Res Health Sci. 2013;2(1):70\u201377."}, {"Citation": "Rao TP, Okamoto T, Akita N, Hayashi T, Kato-Yasuda N, Suzuki K. Amla (Emblica officinalis Gaertn) extract inhibits lipopolysaccharide-induced procoagulant and pro-inflammatory factors in cultured vascular endothelial cells. Br J Nutr. 2013;110(12):2201\u20132206. doi: 10.1017/S0007114513001669.", "ArticleIdList": ["10.1017/S0007114513001669", "23742702"]}, {"Citation": "Thirunavukkarasu M, Selvaraju V, Tapias L, Sanchez JA, Palesty JA, Maulik N. Protective effects of Phyllanthus emblica against myocardial ischemia-reperfusion injury: the role of PI3-kinase/glycogen synthase kinase 3\u03b2/\u03b2-catenin pathway. J Physiol Biochem. 2015;71:623\u2013633. doi: 10.1007/s13105-015-0426-8.", "ArticleIdList": ["10.1007/s13105-015-0426-8", "26342597"]}, {"Citation": "Antony B, Benny M, Kaimal TNB. A pilot clinical study to evaluate the effect of Emblica officinalis extract (AMLAMAX TM) on markers of systemic inflammation and dyslipidemia. Indian J Clin Biochem. 2008;23(4):378\u2013381.", "ArticleIdList": ["PMC3453138", "23105791"]}, {"Citation": "Gopa B, Bhatt J, Hemavathi KG. A comparative clinical study of hypolipidemic efficacy of amla (Emblica officinalis) with 3-hydroxy-3-methylyglutaryl-coenzyme-A reductase inhibitor simvastatin. Indian J Pharmacol. 2012;44(2):238\u2013242. doi: 10.4103/0253-7613.93857.", "ArticleIdList": ["10.4103/0253-7613.93857", "PMC3326920", "22529483"]}, {"Citation": "Usharani P, Fatima N, Muralidhar N. Effects of Phyllanthus emblica extract on endothelial dysfunction and biomarkers of oxidative stress in patients with type 2 diabetes mellitus: a randomized, double-blind, controlled study. Diabetes Metab Syndr Obes. 2013;6:275\u2013284. doi: 10.2147/DMSO.S46341.", "ArticleIdList": ["10.2147/DMSO.S46341", "PMC3735284", "23935377"]}, {"Citation": "Sinha R. R, Sharma N, Advani U, Dadheech G, Kulshreshtha Sh, Parakh R Comparative Study of Hypolipidemic Effects of Atorvastatin With Emblica Officinalis (Amla) In Patients of Type Ii Hyperlipidemia. World J Pharm Res. 2014;3(2):2799\u2013810."}, {"Citation": "Fatima N, Pingali U, Pilli R. Evaluation of Phyllanthus emblica extract on cold pressor induced cardiovascular changes in healthy subjects. Pharmacognosy Res. 2014;6(1):29\u201335. doi: 10.4103/0974-8490.122914.", "ArticleIdList": ["10.4103/0974-8490.122914", "PMC3897005", "24497739"]}, {"Citation": "Fatima N, Pingali U, Muralidhar N. Study of pharmacodynamic interaction of Phyllanthus emblica extract with clopidogrel and ecosprin in patients with type II diabetes mellitus. Phytomed. 2014;21(5):579\u2013585. doi: 10.1016/j.phymed.2013.10.024.", "ArticleIdList": ["10.1016/j.phymed.2013.10.024", "24291054"]}, {"Citation": "Khanna S, Das A, Spieldenner J, Rink C, Roy S. Supplementation of a standardized extract from Phyllanthus emblica improves cardiovascular risk factors and platelet aggregation in overweight/class-1 obese adults. J Med Food. 2015;18(4):415\u2013420. doi: 10.1089/jmf.2014.0178.", "ArticleIdList": ["10.1089/jmf.2014.0178", "PMC4390209", "25756303"]}, {"Citation": "Nain P, Saini V, Sharma S, Nain J. Antidiabetic and antioxidant potential of Emblica officinalis Gaertn leaves extract in streptozotocin-induced type-2 diabetes mellitus (T2DM) rats. J Ethnopharmacol. 2012;142(1):65\u201371. doi: 10.1016/j.jep.2012.04.01441-.", "ArticleIdList": ["10.1016/j.jep.2012.04.01441-", "22855943"]}, {"Citation": "Ansari A, Shahriar MS, Hassan MM, Das SR, Rokeya B, Haque MA. et al. Emblica officinalis improves glycemic status and oxidative stress in STZ induced type 2 diabetic model rats. Asian Pac J Trop Med. 2014;7(1):21\u20135. doi: 10.1016/S1995-7645(13)60185-6.", "ArticleIdList": ["10.1016/S1995-7645(13)60185-6", "24418077"]}, {"Citation": "Shoaib Akhtar M, Ramzan A, Ali A, Ahmad M. Effect of Amla fruit (Emblica officinalis Gaertn) on blood glucose and lipid profile of normal subjects and type 2 diabetic patients. Int J Food Sci Nutr. 2011;62(6):609\u201316. doi: 10.3109/09637486.2011.560565.", "ArticleIdList": ["10.3109/09637486.2011.560565", "21495900"]}, {"Citation": "Gowri BS, Platel K, Prakash J, Srinivasan K. Influence of amla fruits (Emblica officinalis) on the bioavailability of iron from staple cereals and pulses. Nutr Res. 2001;21:1483\u201392. doi: 10.1016/S0271-5317(01)00362-1.", "ArticleIdList": ["10.1016/S0271-5317(01)00362-1"]}]}], "History": [{"Year": "2018", "Month": "1", "Day": "6"}, {"Year": "2018", "Month": "8", "Day": "31"}, {"Year": "2018", "Month": "11", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "11", "Day": "6", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "11", "Day": "6", "Hour": "6", "Minute": "1"}, {"Year": "2018", "Month": "1", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["30386531", "PMC6203864", "10.15171/jcvtr.2018.20"]}}]}